Related by context. All words. (Click for frequent words.) 57 tapentadol ER 56 aripiprazole 56 boosted protease inhibitor 56 certolizumab 55 Pemetrexed 55 desvenlafaxine succinate 55 BENICAR 54 Androgel R 54 tocilizumab 54 HBeAg negative patients 54 noninferiority 54 hypogonadal men 54 MEVACOR 53 factorial design 53 biologic DMARD 53 somatostatin analog 53 tacrolimus ointment 53 AZOR 52 analgesic efficacy 52 IFN alfa 52 § #E 52 Natalizumab 52 HBeAg seroconversion 52 Interferon alfa 52 glatiramer acetate 52 unfractionated heparin UFH 52 Cilostazol 52 CIMZIA ™ 52 eribulin mesylate 52 Elitek 52 fondaparinux 51 Ziprasidone 51 tipranavir r 51 divalproex sodium 51 antiandrogens 51 darunavir ritonavir 51 alteplase 51 Bupropion 51 Dabigatran etexilate 51 Teriflunomide 51 BENICAR HCT 51 UNLOAD 51 4mg/kg 51 relapsing multiple sclerosis 51 DAPT 51 fludarabine cyclophosphamide 51 venlafaxine 51 Rythmol R 51 RIGScan R 51 #mg/m# [001] 51 salmeterol fluticasone 51 apolipoprotein B 51 desvenlafaxine 51 xanthine oxidase inhibitor 50 ASSIGNMENT OF ERROR 50 tapentadol IR 50 Rotigotine 50 ug kg 50 peg interferon 50 solifenacin 50 XEPLION R 50 suppl #S 50 octreotide LAR 50 CsA 50 rt PA 50 glatiramer acetate Copaxone 50 quetiapine 50 QVAR R 50 titrated glipizide 50 MoxDuo TM IR 50 GP IIb IIIa inhibitor 50 ABVD 50 Recap WSH 50 NFV 50 DAS# remission 50 Def. s 50 LAMICTAL 50 Epoetin 49 rFSH 49 peginterferon 49 mitomycin 49 PCWP 49 reuptake inhibitor 49 paroxetine sertraline 49 abstr 49 vorinostat 49 efavirenz EFV 49 PrandiMet TM 49 serum phosphorus 49 Aripiprazole 49 POL PRO 49 valsartan Diovan 49 paricalcitol 49 PIX# [002] 49 placebo controlled clinical 49 piperacillin tazobactam 49 :5 49 AUTOMATIC WITH OVERDRIVE 49 Thrombolysis 49 triple nucleoside 49 Anthony Boissiere FRA 49 Resp't 49 Abilify aripiprazole 49 ACE Inhibitor 49 cilostazol 49 serum uric acid 49 PHASE III 49 bile acid sequestrant 49 INVEGA SUSTENNA 49 ACCORD Lipid 49 angiotensin converting enzyme inhibitors 49 argatroban 49 chemotherapy docetaxel 49 corticosteroid dose 49 § #-#-# b [003] 49 APTIVUS r 49 mITT population 49 Escitalopram 49 Lamotrigine 49 reteplase 49 paliperidone palmitate 48 inhaled anticholinergics 48 subcutaneous SC 48 NSABP B 48 macrophage inflammatory protein 48 SPECIFICS Cotton Valley 48 § #-#.# [001] 48 ACTIVE W 48 RhuDex 48 EMRG POL 48 epoprostenol 48 LBR #-# 48 ARS § 48 HbA 1c 48 STENT 48 asymptomatic metastatic 48 3mg/kg 48 infusional 48 PegIFN 48 concurrent ITP 48 cyclophosphamide methotrexate 48 divalproex 48 pegylated interferon alpha 2a 48 Lupron Depot 48 Talotrexin 48 Tamoxifen Citrate 48 escitalopram 48 CIMZIA R 48 androgen suppression 48 SCIT 48 Repl. 48 periprocedural 48 AGILECT ® 48 Sycrest 48 PegIFN RBV 48 PTNS 48 Duloxetine 48 nonsignificant difference 48 Pl. 48 § #.# [002] 48 JNOV motion 48 HBeAg + 48 Slip op 48 montelukast 48 RU EEU EUROPE ASIA 48 § #.# [004] 48 aldosterone antagonists 48 Aplt 48 5 HT2C receptor 48 tipranavir 48 Pl. s 47 duloxetine Cymbalta 47 Irinotecan 47 Angiox ® 47 Kaplan Meier analysis 47 buproprion 47 Recap NYM 47 CR CRu 47 LUX Lung 47 Intrathecal 47 pramipexole 47 Colo. Sess 47 pregabalin 47 UNI XC 47 cinacalcet 47 #a #a [003] 47 Intervention Effectiveness 47 MoxDuo ® 47 SUMMARY JUDGMENT 47 Perforomist Inhalation Solution 47 adenoma recurrence 47 § § #-#-# [001] 47 guanfacine 47 KAPIDEX 47 methotrexate monotherapy 47 nortriptyline 47 GP IIb IIIa inhibitors 47 ropinirole 47 tolterodine 47 antidepressant efficacy 47 β blocker 47 NJSA #:# C 47 MC# [001] 47 SDNY Mar. 47 SSRI citalopram 47 ritonavir boosted lopinavir 47 EMRG VIO 47 sargramostim 47 Gazeta Wyborcza pp. 47 baclofen 47 agomelatine 47 clomipramine 47 donepezil Aricept 47 Recap HOU 47 ERISA § 47 titration phase 47 Induction Chemotherapy 47 Lu AA# 47 Compl 47 adjunctive ABILIFY 47 PTI SJY 47 clopidogrel Plavix 47 GOVERNMENT MEETINGS 47 clopidogrel 47 ALT elevation 47 Recap LAA 47 TIMP 1 47 immunomodulatory therapy 47 PUFA intake 47 milrinone 47 guanfacine extended release 46 Circuit LAR 46 venlafaxine Effexor 46 BCNS 46 ER CHOP 46 Opening Br 46 MADRS score 46 ACUITY trial 46 IV bolus formulation 46 phenelzine 46 rs# [004] 46 squamous cell histology 46 calcium antagonist 46 pp. #-# fn 46 MEND CABG 46 CIPN 46 citalopram Celexa 46 sertraline Zoloft 46 NJSA 2A :# 46 HA RA 46 Code § #-# [001] 46 Mirtazapine 46 gemcitabine Gemzar ® 46 appellant asserts 46 edoxaban 46 amphotericin B 46 Reproduced Record RR 46 Recap OAK 46 Recap CIN 46 Epoprostenol 46 antithrombotics 46 univariate 46 La. RS #:# [003] 46 antiplatelet 46 fibrinolytic 46 MARKET SIZE 46 RU EUROPE ASIA EEU 46 NJSA 2A #A 46 Declares Dividend Quick Facts 46 reboxetine 46 NJSA #A 46 § #-# [004] 46 Levofloxacin 46 IONSYS TM 46 androgen deprivation 46 Pelvic Organ Prolapse 46 Randomized controlled 46 sertraline 46 lipid lowering drugs 46 citalopram 46 MAINTENANCE TECH 46 PROVIDING FOR 46 Lucentis monotherapy 46 CZP 46 normal ULN 46 #.#-# b [001] 46 Reply Brief 45 biologic DMARDs 45 acamprosate 45 Spiriva Handihaler 45 Cardiotoxicity 45 EFFEXOR XR 45 § #-#-# c [001] 45 SPECIFICS Hosston 45 NMDA antagonist 45 Puls Biznesu pp. 45 Exh 45 nonresponders 45 PANSS Positive 45 tenecteplase 45 leukotriene receptor antagonist 45 conjugated equine estrogens 45 EtOH 45 N acetylcysteine 45 #.# subd [004] 45 hemodynamic variables 45 immunoconjugate 45 AUTOMATIC SEQUENTIAL PORT 45 CRMD# 45 Venlafaxine 45 pegylated alpha interferon 45 SSRI SNRI 45 QVAR ® 45 Ranibizumab 45 Dacogen decitabine 45 Recap NYY 45 Sumatriptan OS 45 ENDOMETRIN 45 Defs. 45 Zevalin consolidation 45 IXEMPRA 45 Cetuximab 45 selenium supplementation 45 ESMO Accepted Abstract 45 Judgments § 45 Powdered Activated Carbon 45 lipid lowering therapy 45 neurocognitive function 45 adjuvant endocrine therapy 45 NJSA #:#-# [004] 45 docetaxel emulsion 45 § 7A 45 substantively unconscionable 45 Recap BAL 45 neuroleptic 45 Exenatide Byetta 45 severe neutropenia 45 Histalean 45 Paroxetine 45 fibrinolytic therapy 45 lopinavir ritonavir Kaletra 45 spud #-#-# drlg [002] 45 lamivudine zidovudine 45 intravesical 45 GHRH 45 DTPA 45 TEMODAL 45 Timed Walk 45 anti androgen 45 HYVET 45 oral prednisolone 45 mg/# mL [001] 45 LSA RS #:# [001] 45 pharmacologic therapy 45 AG# [003] 45 CFR § #.# [007] 45 USC § #d 45 § #-# [003] 45 DC Code § 45 PTI CORR 45 donepezil 45 § #.#.# [002] 45 INITIATE 45 recombinant tissue plasminogen 45 fibrinolysis 45 pegnivacogin 45 LHRH agonists 45 anagrelide 45 serotonin reuptake inhibition 45 marketed pegylated interferons 45 F. Supp 45 bupropion 45 PTI MIJ 45 CAPRA 45 Instanyl 45 Clarithromycin 45 duloxetine 45 μV 45 BARI 2D 45 Angiox R 45 hetastarch 44 dose escalation phase 44 § #-#-# [002] 44 thrombolytic 44 NasalFent 44 RU EUROPE EEU ASIA 44 clinical pharmacology studies 44 HNRC 44 SIMPADICO 44 Imiquimod 44 Valdoxan 44 Reply Br 44 Skip Galan 44 mTOR mammalian target 44 #.#A [005] 44 CELESTICA 44 receptor antagonism 44 clinically meaningful improvement 44 doxorubicin docetaxel 44 uremic pruritus 44 ml min 44 pyridostigmine 44 b Vernon Supp 44 imipenem 44 adult chronic ITP 44 WNTSU 44 thrombus aspiration 44 cells mcL 44 See TCA § 44 ACQUIRED BY 44 HOMA IR 44 Recap TOR 44 Docket # 44 predialysis 44 NJSA #:# [001] 44 See USSG § #B#.# 44 Consensus +#.# 44 Dkt 44 natalizumab 44 Pain Rating Scale 44 WAS CONTACTED 44 Sanvar R 44 1ST ADD 44 paroxetine 44 IRESSA 44 See id 44 USSG § #B#.# [002] 44 Section #-#-# [004] 44 adiponectin concentrations 44 LidoPAIN R 44 Cladribine tablets 44 RU EUROPE EEU EMRG 44 soluble CD# 44 IT IS ORDERED 44 Evid. Code § § 44 SUBDIVISION 44 Consolidated Amended Complaint 44 Petitioner contends 44 Section #.#.# [001] 44 Telintra 44 Guides FY# Quick Facts 44 rimonabant #mg 44 § #A [001] 44 Chevrolet SILVERADO 44 spud #-#-# drlg [003] 44 Fluoxetine 44 Repeatability 44 ALL LANES 44 HONDA ACCORD 44 Vectibix monotherapy 44 intravenous tissue plasminogen 44 PROWESS 44 ProShares UltraShort ETFs 44 metered dose inhaler MDI 44 CFR § #.# [004] 44 UDCA 44 HDRS 44 LMWHs 44 WNWCPL 44 methylphenidate HCl 44 NY ab rh 44 anticholinergic medication 44 Galp Energia EURONEXT GALP 44 Derek Reber Lewisburg 44 § #.#-# [001] 44 imipramine 44 LUTS 44 DOMINICAN COLLEGE 44 Major Depressive Disorder 44 RICARDO F. 44 mso ansi language 44 GP IIb IIIa 44 biguanide 44 LITHIA MOTORS 44 ED Tex. 44 glucocorticoid induced 44 INVEGA ® 44 systemic immunosuppressive drugs 44 subscores 44 Stmt 44 κ 44 TriRima 44 LH RH 44 RISPERDAL ® 44 CFR #.# [008] 44 BH AR End 43 WISCONSIN STAT 43 OCGA § #-#-# [007] 43 Dkt. No. 43 lipid lowering medications 43 RICE BRAN Rs 43 Pharmacologic 43 mso fareast language 43 HORIZONTAL 43 § #-#-# [004] 43 RC #.# B [002] 43 Preliminary plat 43 paroxetine Paxil 43 -#.# ± [002] 43 UNDER PRESSURE DOWN 43 AMBIEN CR 43 § 7B 43 ZHB 43 EXJADE 43 section #.# 43 A1c levels 43 § #-#-# [001] 43 ASCT 43 Montgomery Åsberg Depression 43 Fed. Cl 43 NJAC 6A 43 idiopathic Parkinson disease 43 chemotherapeutic regimen 43 rhMBL 43 #.# subd [006] 43 WCJ erred 43 clopidogrel pretreatment 43 Rehearing En Banc 43 TAGS PGOV 43 PT# Pro 43 NOTIFICATION OF MAJOR INTERESTS 43 Fibrillex TM 43 :2 43 LPS induced 43 EOX 43 Tissue Plasminogen Activator 43 appellants contend 43 Appellants 43 prospectively stratified 43 Compl. ¶ 43 § #:# [001] 43 NovoSeven RT 43 TGZ 43 Fed.R.Civ.P. 43 selective serotonin 43 cholinesterase inhibitor 43 CEQA Guidelines 43 KKW 43 ToGA 43 THOMPSON CREEK METALS 43 Medium Density Residential 43 CNS LS 43 Section #-#-# [006] 43 engineered anticoagulant 43 risperidone Risperdal 43 anxiolytic 43 Merit Sys 43 IRCP 43 serotonin reuptake inhibitor 43 Atomoxetine 43 ENTREE GOLD 43 pp. #-# italics 43 TCA § #-#-# [003] 43 FXIII 43 mM NaCl 43 μg liter 43 serum HBV DNA 43 EQ 5D 43 E #mm f/#.#L 43 APEX AMI 43 Lactobacillus KW 43 NCruz Texas 43 pegylated interferon ribavirin 43 RESOLUTION NO 43 ziconotide 43 CFR § #.# [002] 43 E2 CLO 43 androgen blockade 43 systolic hypertension 43 #B.# [002] 43 DP b# 43 STIFEL FINANCIAL 43 dkt item 43 mH 43 antithrombotic therapy 43 SUMMARY NOTICE OF 43 BPS IC 43 CFR § #.# [006] 43 #/Aug 43 Compl. 43 G# [006] 43 plasma cortisol 43 Fuster V 43 Tr. 43 NE ¼ 43 i NOTIFICATION OF 43 CONSTRUCTION INC. 43 Subphase 43 oral anticoagulation 43 Docket Nos. 43 § #a [002] 43 WNWCZM 43 Subcutaneous 43 intravesical chemotherapy 43 NCGS § 43 gonadotropin releasing hormone GnRH 43 Competitive Impact Statement 43 Relapsing remitting 43 Pls. 43 § #-#-# b [001] 43 PIA9 43 CFR #.# [007] 43 SAMe 42 Xalatan R 42 Prolonged Exposure 42 symptomatic hyponatremia 42 Aggressive Drug Evaluation 42 CPE WAN 42 Meta analyzes 42 cholinesterase inhibitors 42 Functional Assessment 42 NW ¼ 42 Knut Bitustoeyl 42 Southeast Anesthesiology Consultants 42 SHOTS ON GOAL 42 Bipolar Mania 42 Fam. Code § 42 LGG 42 § #.# [003] 42 Appellants assert 42 KL WN 42 Desorption 42 leukocytosis 42 Zemplar 42 Supervisor Wilensky 42 Cyanokit R 42 #-#.# [016] 42 :4 42 PSVT 42 Dkt. # 42 § #-#-# [003] 42 #a #a [001] 42 Biojector 42 ECV Sunnex 42 APEX AMI trial 42 Plaintiff asserts 42 TROPOS 42 FEHA 42 USSG § 42 Fibromyalgia Syndrome 42 Respondent contends 42 Rzeczpospolita pp. A1 42 syndromal 42 Bankr. WD Mo. 42 BIO SET 42 ACCLAIM 42 SW ¼ 42 Lofexidine 42 NOPR 42 Doc. No. 42 Radiat 42 spud #-#-# drlg [004] 42 #R# [010] 42 Petitioner argues 42 prazosin 42 Ord. 42 PTI COR 42 R lisdexamfetamine dimesylate 42 tryptophan depletion 42 § #.# b 42 CFR § #.# [003] 42 atherosclerotic renal artery stenosis 42 POWER BRAKES POWER DOOR 42 DRILL HOLE 42 adenotonsillectomy 42 Oropharyngeal Candidiasis 42 CONSULTING SERVICES 42 GRANTED IN 42 PHAST 42 RRMS patients 42 Def. 42 recombinant follicle stimulating 42 MORGAN STANLEY RAISED ITS 42 injunction precluding 42 Recap DET 42 mITT 42 Toby Cheff Ronan 42 RESPONSE FROM 42 By Suria Rina 42 Idaho Code § 42 Central Venous Catheter 42 uptake inhibitors SSRIs 42 Prelox 42 QUALIFYING TRANSACTION 42 CODE § 42 END PART 42 RCTs 42 cortical stimulation 42 affirmance 42 LSA RS #:# [002] 42 MIG Verwaltungs AG 42 § #-# [001] 42 MORE THAN TREAS 42 Desferal 42 tissue plasminogen activator 42 BY MONIQUE 42 PEY 42 Recap TEX 42 ISOCOUNTRY3 42 #.# subds [001] 42 EÜ 42 B#.# [001] 42 TreeHouse Reseller View 42 WBPA 42 CLO RP 42 CORD II 42 HOLDCO 42 RC #.# B [001] 42 SECURITIES LITIGATION 42 ADJUDGED 42 #-#.# [017] 42 DR #-# 42 BOARD OF ADJUSTMENT 42 advanced hepatocellular carcinoma 42 acute mania 42 TRUS 42 § § #.# [002] 42 § #-#.# [002] 42 Reclast zoledronic acid 42 Serum creatinine 42 BEXXAR Therapeutic Regimen 42 judicial estoppel 42 Guides FY# Update 42 pegylated liposomal doxorubicin PLD 42 Pegasys plus Copegus 42 NeuroStar TMS Therapy 42 TRANSY 42 HyQ 42 Kogenate ® FS 42 CALERIE 42 #.#L GDI engine 42 CENTERPOINT 42 PIA CAR 42 Scott Wolfinger Quakertown 42 WNWA 42 § #-#-# [008] 42 Supp. 42 § #-#-# [006] 42 randomized controlled trials 42 Sentencing Guidelines Manual 42 PANSS scores 41 protein tyrosine phosphatase 41 ALISTA 41 Verified Complaint 41 OPTIMIZER 41 KSA #-# d 41 Sensor Interface 41 ^ ^ sup 41 WORCESTER PREP 41 = #.#-#.# 41 L#F 41 CONFIG 41 GPi 41 Main Outcome Measure 41 HRSD 41 NVQ4 41 buprenorphine naloxone 41 OAB symptoms 41 RESOURCES CORPORATION 41 CREON ® 41 Puls Biznesu p.# 41 B1 B2 B3 41 randomisation 41 SE ¼ 41 CERTIFICATION FOR 41 IS# [004] 41 Fibrostat R 41 transarterial 41 OCGA § #-#-# [004] 41 interpersonal psychotherapy 41 Exercising jurisdiction 41 :3 41 CD3 + 41 #.# 5T 41 NOTIFICATION OF MAJOR INTEREST 41 § #B#.# [002] 41 EUROPE ASIA EEU EMRG 41 postprandial hyperglycemia 41 MC FP 41 Viveta 41 Kirby Markowsky 41 fluoxetine 41 CrR #.# 41 Mimetics 41 § #-#-# b [002] 41 NJSA #:# [002] 41 #WB [001] 41 DPNP 41 MOVES AHEAD 41 neuroleptics 41 5 HTTLPR 41 BioMarck 41 Birner Dental 41 RELATIVE TO 41 HOLE NO 41 Respondent concedes 41 IRX 41 affective psychosis 41 Peristaltic Pumps 41 Hr'g Tr 41 topical corticosteroids 41 ENACT 41 section #-#-# [002] 41 PS § § 41 DEVELOPMENT CORP. 41 Appellants argue 41 NRS #.# [001] 41 PROactive study 41 DepoDur TM 41 H1 NET PROFIT 41 ADOPTION OF THE 41 #.#a [003] 41 Civ. Code § 41 § #-# [002] 41 BLOSSOM 41 OZG 41 SCRUBBING 41 DCCT 41 Inc. LCV RA 41 transcranial Doppler ultrasound 41 CONT 41 MDRD 41 ischemic stroke 41 Rule #:#-# e 41 Final Judgments 41 factfinder 41 Trafigura Ventures 41 MH Faceoff 41 patentee 41 doc. 41 Pa.RAP 41 OFFSET 41 USCS § 41 § #A.# 41 anticholinergics 41 Insertion Loss 41 chronic prostatitis chronic 41 TFR UFN 41 covariate 41 Arch Surg 41 p laintiff 41 DESCRIPTION COMPOSITION INFORMATION 41 metastatic relapsed 41 Nonexempt 41 #B.# [001] 41 claim preclusion 41 promissory fraud 41 § #.# [001] 41 NJSA #:#-# [001] 41 MetS 41 antioxidant supplementation 41 Peritoneal Dialysis 41 EECP therapy 41 Ohio Adm.Code #-#-# 41 PNES 41 § #E#.# 41 STREAMLINE 41 KRS #A.# [002] 41 TOPAMAX ® 41 JETSTREAM G3 41 DMBA 41 BORSA 41 NYSEAmex 41 PS § 41 Methylphenidate 41 Rev Bds 41 Reasonable Suspicion 41 No. #AP 41 QoL 41 adenosine deaminase 41 relapsed Hodgkin lymphoma 41 uncontroverted facts 41 virological response 41 HZW 41 flibanserin #mg 41 warfarin therapy 41 Activase 41 MEMBERSHIP IN 41 Recap CLE 41 VOGT electronic 41 REVIEW BOARD 41 selective serotonin reuptake inhibitor 41 END FOOTNOTE 41 diabetes mellitus DM 41 WILMINGTON TRUST 41 paclitaxel Taxol R 41 Backs FY# Forecast 41 Naltrexone 41 Grupo Mexicano 41 SPECIFICATIONS 41 tumor vascular disrupting 40 Multivariate analysis 40 GIGABYTE GV 40 IVIg 40 LDB CPR 40 #:# [013] 40 EÖ 40 Fresenius Med 40 No. CA# 40 Bilgena Read Terms 40 somatostatin analogs 40 peginterferon alpha 40 thrombolytic therapy 40 PIA XI top 40 Equivalence 40 Personalized Chemotherapy 40 rtPA 40 UCBR 40 p laintiffs 40 #,#-# [008] 40 CONVERSION OF 40 doc. # 40 SENIOR HOUSING 40 luteal phase 40 serotonergic 40 K DOQI 40 RCW #.#A.# 40 Id. 40 Enabling Clause 40 adjuvant systemic 40 euthymic 40 Europees 40 CASE NUMBER 40 FJA AG 40 ACCOUNTING CLERK 40 ENTITY 40 purposeful availment 40 Neutropenia 40 GARA 40 REQUEST FOR PROPOSALS 40 IN EACH 40 LTRA 40 rhITF 40 pL 40 SHAREHOLDERS MEETING 40 WS RX 40 +# VDC 40 First Amended Complaint 40 BKT SA 40 PROMETA 40 grievant 40 TRANs F1 + 40 amdt 40 CREON R 40 Port Auth 40 NJSA #:#-#.# [003] 40 arbitrability 40 Gunderson JG 40 ab rh bi 40 L methionine 40 BKT DAL 40 u pon 40 Ark. R. Civ 40 Rule #:#-# [002] 40 L. reuteri 40 lymphotoxin 40 NTQ 40 Membership Dues 40 UTILIZATION 40 Fixed remuneration 40 CONCERTA ® 40 Second Amended Complaint 40 EECP R 40 Bankruptcy Code § 40 4A 4B 40 BKT GS 40 nondepressed 40 sua sponte duty 40 Ed Zadylak 40 plaintiffs appellees 40 minocycline 40 CFR § #.# [005] 40 b ased upon 40 HRS § 40 BEXXAR 40 daytime somnolence 40 Selective serotonin reuptake inhibitors 40 Appellant 40 CITIGROUP INC. 40 section #-#-# [001] 40 varenicline Chantix 40 parol evidence 40 Stott Cntr Portland 40 Appellant contends 40 section #-#-# [003] 40 RIGL 40 STEMI patients 40 GAMMON GOLD 40 State Farm Mut 40 MHPAEA 40 nonmetastatic prostate cancer 40 Section #.# [002] 40 randomized controlled trials RCTs 40 d efendants 40 CrR 40 nondischargeability 40 Baseline characteristics 40 AETD 40 CFR #.# [005]